CSNpharm
Scopine HCl salt is a naturally occuring α1-adrenergic receptor agonist and used in the treatment of acute circulatory shock and also s a potential brain-targeting moiety for enhancing the brain uptake efficiency of chlorambucil.
More Information
Supplier Page
CSNpharm
Methyl 3-(2,4-dihydroxyphenyl)propionate, a natural product isolated and purified from the herbs of Juniperus formosana, has inhibitory effects on tyrosinase, antioxidant ability, and lightening effect of ultraviolet B (UVB)-induced hyperpigmentation.
More Information
Supplier Page
CSNpharm
Methyl 3-(2,4-dihydroxyphenyl)propionate, a natural product isolated and purified from the herbs of Juniperus formosana, has inhibitory effects on tyrosinase, antioxidant ability, and lightening effect of ultraviolet B (UVB)-induced hyperpigmentation.
More Information
Supplier Page
CSNpharm
Methyl 3-(2,4-dihydroxyphenyl)propionate, a natural product isolated and purified from the herbs of Juniperus formosana, has inhibitory effects on tyrosinase, antioxidant ability, and lightening effect of ultraviolet B (UVB)-induced hyperpigmentation.
More Information
Supplier Page
CSNpharm
BMY 7378 2HCl is a 5-HT1A partial agonist and a high-affinity α1D adrenoceptor antagonist with Ki values of 2, 800 and 600 nM for cloned rat α1D, rat α1A and hamster α1B receptors respectively.
More Information
Supplier Page
CSNpharm
LY333531 is a β-specific protein kinase C inhibitor. It competitively and reversibly inhibits PKCβ1 and PKCβ2 with IC50 values of 4.7 and 5.9 nM respectively.
More Information
Supplier Page
CSNpharm
LY333531 is a β-specific protein kinase C inhibitor. It competitively and reversibly inhibits PKCβ1 and PKCβ2 with IC50 values of 4.7 and 5.9 nM respectively.
More Information
Supplier Page
CSNpharm
LY333531 is a β-specific protein kinase C inhibitor. It competitively and reversibly inhibits PKCβ1 and PKCβ2 with IC50 values of 4.7 and 5.9 nM respectively.
More Information
Supplier Page
CSNpharm
LY333531 is a β-specific protein kinase C inhibitor. It competitively and reversibly inhibits PKCβ1 and PKCβ2 with IC50 values of 4.7 and 5.9 nM respectively.
More Information
Supplier Page
CSNpharm
LY333531 is a β-specific protein kinase C inhibitor. It competitively and reversibly inhibits PKCβ1 and PKCβ2 with IC50 values of 4.7 and 5.9 nM respectively.
More Information
Supplier Page